Monaco RTP System Radiation Therapy Treatment Planning System. Radiation treatment planning.
Published October 2, 2013 · Recall initiated: May 22, 2013
Summary
FDA records medical device Class II recall Z-2277-2013, published October 2, 2013 and initiated May 22, 2013. Recalling firm: Elekta, Inc.; Status: Terminated; Reported quantity: 72; Lot: All versions of Monaco. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Patient needs to be positioned as indicated by the treatment plan.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Elekta, Inc.
- Distributor
- Distributed in Puerto Rico and the states of AK, AZ, CA, CO, CT, FL, IL, IN, MA, MD, MI, MN, MO, NC, NJ, NM, NY, OH, OK, OR, PA, RI, SC, TN, TX, VA, and WA.
- Lot
- All versions of Monaco
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDABrand Name: Geneva Product Name: Brachytherapy Applicator Product Description: The device is intended forJuly 15, 2026
- FDABrand Name: Brachytherapy Applicator Product Name: Advanced Gynecological Applicator Product Description: TheJuly 15, 2026
- FDABrand Name: Fletcher CT/MR Shielded Applicator Set Product Name: Intracavitary Remote Afterloading ApplicatorJuly 15, 2026
- FDAMOSAIQ Oncology Information SystemJune 17, 2026
- FDAMonaco RTP System Radiation treatment planningOctober 2, 2013
- FDASynthes 3.5 MM LCP(R) Distal Humerus System The Synthes 3.5 MM LCP Distal Humerus System is intended forOctober 2, 2013
Questions about this recall
Was Monaco RTP System Radiation Therapy Treatment Planning System. Radiation treatment planning. recalled?
Yes. FDA published recall Z-2277-2013 on October 2, 2013. Reported hazard: Patient needs to be positioned as indicated by the treatment plan.
What should I do if I have this product?
Voluntary: Firm initiated · Letter